Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bacterial diversity of the Colombian fermented milk “Suero Costeño” assessed by culturing and high-throughput sequencing and DGGE analysis of 16S rRNA gene amplicons

  • Motato, Karina Edith
  • Milani, Christian
  • Ventura, Marco
  • Valencia, Francia Elena
  • Ruas-Madiedo, Patricia
  • Delgado, Susana
“Suero Costeño” (SC) is a traditional soured cream elaborated from raw milk in the Northern-Caribbean coast of Colombia. The natural microbiota that characterizes this popular Colombian fermented milk is unknown, although several culturing studies have previously been attempted. In this work, the microbiota associated with SC from three manufacturers in two regions, “Planeta Rica” (Córdoba) and “Caucasia” (Antioquia), was analysed by means of culturing methods in combination with high-throughput sequencing and DGGE analysis of 16S rRNA gene amplicons. The bacterial ecosystem of SC samples was revealed to be composed of lactic acid bacteria belonging to the Streptococcaceae and Lactobacillaceae families; the proportions and genera varying among manufacturers and region of elaboration. Members of the Lactobacillus acidophilus group, Lactocococcus lactis, Streptococcus infantarius and Streptococcus salivarius characterized this artisanal product. In comparison with culturing, the use of molecular in deep culture-independent techniques provides a more realistic picture of the overall bacterial communities residing in SC. Besides the descriptive purpose, these approaches will facilitate a rational strategy to follow (culture media and growing conditions) for the isolation of indigenous strains that allow standardization in the manufacture of SC., This study was supported by Spanish Ministry of Economy and Competitiveness partially funded by European Union FEDER (project reference AGL2015-64901-R). The cooperation project COOPA20057 (funded by CSIC), between IPLA-CSIC (Spain) and Antioquia University (Colombia) allowed several short stays of K.E. Motato at IPLA-CSIC. S. Deldado is supported by a Postdoctoral research contract associated to a project from the Spanish “Plan Estatal de I+D+ i” research plan (project reference BIO2014-55019-JIN), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bifidobacteria and their health-promoting effects

  • Hidalgo-Cantabrana, Claudio
  • Delgado, Susana
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
  • Sánchez García, Borja
Bifidobacteria are members of the intestinal microbiota of mammals and other animals, and some strains are able to exert health-promoting effects. The genus Bifidobacterium belongs to the Actinobacteria phylum. Firmicutes, Bacteroidetes, and Actinobacteria constitute the most abundant phyla in the human intestinal microbiota, Firmicutes and Bacteroidetes being predominant in adults, and Actinobacteria in breast-fed infants, where bifidobacteria can reach levels higher than 90% of the total bacterial population. They are among the first microbial colonizers of the intestines of newborns, and play key roles in the development of their physiology, including maturation of the immune system and use of dietary components. Indeed, some nutrients, such as human milk oligosaccharides, are important drivers of bifidobacterial development. Some Bifidobacterium strains are considered probiotic microorganisms because of their beneficial effects, and they have been included as bioactive ingredients in functional foods, mainly dairy products, as well as in food supplements and pharma products, alone, or together with, other microbes or microbial substrates. Well-documented scientific evidence of their activities is currently available for bifidobacteria-containing preparations in some intestinal and extraintestinal pathologies. In this review, we focus on the role of bifidobacteria as members of the human intestinal microbiota and their use as probiotics in the prevention and treatment of disease., Research in our group is supported by grants AGL2015- 64901-R, BIO2014-55019-JIN, AGL2013-44761-P, and AGL2013-44039-R from the Spanish Ministry of Economy and Competitiveness, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bifidobacteria and their molecular communication with the immune system

  • Ruíz García, Lorena
  • Delgado, Susana
  • Ruas-Madiedo, Patricia
  • Sánchez García, Borja
  • Margolles Barros, Abelardo
Bifidobacterium represents a genus within the phylum Actinobacteria which is one of the major phyla in the healthy intestinal tract of humans. Bifidobacterium is one of the most abundant genera in adults, but its predominance is even more pronounced in infants, especially during lactation, when they can constitute the majority of the total bacterial population. They are one of the pioneering colonizers of the early gut microbiota, and they are known to play important roles in the metabolism of dietary components, otherwise indigestible in the upper parts of the intestine, and in the maturation of the immune system. Bifidobacteria have been shown to interact with human immune cells and to modulate specific pathways, involving innate and adaptive immune processes. In this mini-review, we provide an overview of the current knowledge on the immunomodulatory properties of bifidobacteria and the mechanisms and molecular players underlying these processes, focusing on the corresponding implications for human health. We deal with in vitro models suitable for studying strain-specific immunomodulatory activities. These include peripheral blood mononuclear cells and T cell-mediated immune responses, both effector and regulatory cell responses, as well as the modulation of the phenotype of dendritic cells, among others. Furthermore, preclinical studies, mainly germ-free, gnotobiotic, and conventional murine models, and human clinical trials, are also discussed. Finally, we highlight evidence supporting the immunomodulatory effects of bifidobacterial molecules (proteins and peptides, exopolysaccharides, metabolites, and DNA), as well as the role of bifidobacterial metabolism in maintaining immune homeostasis through cross-feeding mechanisms., LR is a postdoctoral researcher supported by the Juan de la Cierva Postdoctoral Trainee Program of the Spanish Ministry of Economy and Competitiveness (MINECO; IJCI-2015-23196). BS and AM thanks MINECO for the funding of the project AGL2016-78311-R and PR-M for the project AGL2015-64901-R. SD is supported by a research contract associated to the project BIO2014-55019-JIN from the Spanish “Plan Estatal de I+D+i”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chemical and biological properties of the novel exopolysaccharide produced by a probiotic of Bifidobacterium longum

  • Inturri, Rosanna
  • Molinaro, Antonio
  • Di Lorenzo, Flaviana
  • Blandino, Giovanna
  • Tomasello, Barbara
  • Hidalgo-Cantabrana, Claudio
  • De Castro, Cristina
  • Ruas-Madiedo, Patricia
Bifidobacterium longum W11 is a commercialized probiotic that has an exopolysaccharide (EPS) layer covering its surface which could play a role in the beneficial properties attributed to the strain; thus, we have carried out chemical and biological analyses of this polymer. The eps cluster putatively involved in the polymer synthesis presented a unique structural organization not previously reported in bifidobacteria. B. longum W11 produced a complex polysaccharide blend with the main component composed of glucose and galactose. An exhaustive structural analysis identified two different repeating units: one linear [→6)-β-Galf-(1→3)-α-Galp-(1→] and one, more abundant, with the same backbone in which the β-Galf is 5-substituted by a β-Glcp unit. The antioxidant capability and the lack of toxicity of the whole EPS W11 mixture, as well as some functional characteristics of the producing strain, such as the in vitro resistance to gastrointestinal conditions and the adhesion of colonocytes, were also determined., The authors acknowledge to the Spanish Ministry of Economy, Industry and Competitiveness (MINEICO) and FEDER funds for the financial support through the project AGL2015-64901-R. The authors also thank the Italian Ministry of Education, University and Research for the fellowship PON 01_01802 and the University of Catania for a grant application (FIR2014)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gene replacement and fluorescent labeling to study the functional role of exopolysaccharides in Bifidobacterium animalis subsp. lactis

  • Castro-Bravo, Nuria
  • Hidalgo-Cantabrana, Claudio
  • Rodríguez-Carvajal, Miguel A.
  • Ruas-Madiedo, Patricia
  • Margolles Barros, Abelardo
An extracellular layer of exopolysaccharides (EPS) covers the surface of some Bifidobacterium animalis subsp. lactis strains, which could be of relevance for its probiotic performance. In order to understand the functional characteristics of B. animalis subsp. lactis, two isogenic strains that differ in their EPS-producing phenotype, due to a single mutation in the gene Balat_1410, were studied. By means of a double crossover recombination strategy, successfully used for the first time in bifidobacteria, Balat_1410 in the type strain B. animalis subsp. lactis DSM10140 was replaced by a mutated gene containing a non-synonymous mutation previously associated with the appearance of a mucoid-ropy phenotype. Nuclear magnetic resonance and SEC-MALS analyses showed that the novel strain harboring the mutation acquired a ropy phenotype, due to the production of a high molecular weight (HMW)-EPS that is not produced in the wild-type strain. Fluorescence labeling of both strains with two fluorescent proteins, m-Cherry and Green Fluorescent Protein, was achieved by expressing the corresponding genes under the control of a native selected promoter (the elongation factor Tu promoter). Remarkably, qualitative and quantitative fluorescence analyses demonstrated that the ropy strain displays a lower capability to adhere to human intestinal epithelial cells. In addition, the presence of the HMW-EPS reduced the capability of the producing strain to form biofilms upon three different abiotic surfaces. This work also highlights the fact that different EPS confer variable functional characteristics to the bifidobacterial surface, which may be relevant for the performance of B. animalis subsp. lactis as a probiotic. The construction of molecular tools allowing the functional characterization of surface structures in next generation probiotics is still a challenging issue that deserves further attention, given the relevant role that such molecules must play in the interaction with the host., This work was financed by the Spanish Ministry of Economy and Competitiveness (MINECO) and FEDER European Union funds through the project AGL2015-64901-R. NC-B acknowledges her FPI (BES-2013-063984) fellowship to MINECO, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Interactions of surface exopolysaccharides from bifidobacteriumand lactobacilluswithin the intestinal environment

  • Castro-Bravo, Nuria
  • Wells, Jerry M.
  • Margolles Barros, Abelardo
  • Ruas-Madiedo, Patricia
Exopolysaccharides (EPS) are surface carbohydrate polymers present in most bacteria acting as a protective surface layer but also interacting with the surrounding environment. This review discusses the roles of EPS synthesized by strains of Lactobacillus and Bifidobacterium, many of them with probiotic characteristics, in the intestinal environment. Current knowledge on genetics and biosynthesis pathways of EPS in lactic acid bacteria and bifidobacteria, as well as the development of genetic tools, has created possibilities to elucidate the interplay between EPS and host intestinal mucosa. These include the microbiota that inhabits this ecological niche and the host cells. Several carbohydrate recognition receptors located in the intestinal epithelium could be involved in the interaction with bacterial EPS and modulation of immune response; however, little is known about the receptors recognizing EPS from lactobacilli or bifidobacteria and the triggered response. On the contrary, it has been clearly demonstrated that EPS play a relevant role in the persistence of the producing bacteria in the intestinal tract. Indeed, some authors postulate that some of the beneficial actions of EPS-producing probiotics could be related to the formation of a biofilm layer protecting the host against injury, for example by pathogens or their toxins. Nevertheless, the in vivo formation of biofilms by probiotics has not been proved to date. Finally, EPS produced by probiotic strains are also able to interact with the intestinal microbiota that populates the gut. In fact, some of these polymers can be used as carbohydrate fermentable source by some gut commensals thus being putatively involved in the release of bacterial metabolites that exert positive benefits for the host. In spite of the increasing knowledge about the role that these surface molecules play in the interaction of probiotic bacteria with the gut mucosal actors, both intestinal receptors and microbiota, the challenging issue is to demonstrate the functionality of EPS in vivo, which will open an avenue of opportunities for the application of EPS-producing probiotics to improve health., In the MicroHealth group this research topic is currently financed by the project AGL2015-64901-R (including FEDER European Union funds) from the Ministry of Economy, Industry and Competiveness (MINECO). NC-B acknowledges her FPI fellowship to the MINECO (BES2013-063984)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Real-time monitoring of HT29 epithelial cells as an in vitro model for assessing functional differences among intestinal microbiotas from different human population groups

  • Nogacka, Alicja
  • Ruas-Madiedo, Patricia
  • Gómez López, Esther
  • Solís, Gonzalo
  • Fernández, Nuria
  • Suárez, Marta
  • Suárez, Ana
  • Salazar, Nuria
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
Several in vitro screening tests have been used for selecting probiotic strains; however they often show low predictive value and only a limited number of strains have demonstrated functionality in vivo. The most used in vitro tests represent a very simplified version of the gut environment, especially since they do not consider the accompanying microbiota. Therefore, there is a need to develop sensitive and discriminating in vitro models including the microbiota. Here we developed an in vitro model to discriminate among microbiotas/fecal waters from different population groups. To this end samples were obtained from seven healthy adults, five IBD-patients, ten full-term and ten preterm newborns. Fecal microbiotas were purified and their impact, as well as that of the fecal waters, on HT29 cells was continuously monitored for 22 h using a real-time cell analyzer (RTCA). The composition of the purified microbiotas was assessed by 16S rRNA gene profiling and qPCR and the levels of short chain fatty acids (SCFA) determined by gas chromatography. The microbiota fractions and SCFA concentrations obtained from IBD-patients, full-term and preterm babies, showed clear differences with regard to those of the control group (healthy adults). Moreover, the purified intestinal microbiotas and fecal waters also differed from the control group in the response induced on the HT29 cells assay developed. In short, we have developed a real-time, impedance-based in vitro model for assessing the functional response induced by purified microbiotas and fecal waters upon intestinal epithelial cells. The capability of the assay for discriminating the functional responses induced, by microbiotas or fecal waters from different human groups, promises to be of help on the search for compounds/strains to restore the functionality of the microbiota-host's interaction., This work was financed by projects AGL2013-43770-R and AGL2015-64901-R from Plan Estatal de I + D + I (Spanish Ministry of Economy and Competitiveness, MINECO) and by Grant GRUPIN14-043 from Plan Regional de Investigación del Principado de Asturias, Spain. Both national and regional grants received cofounding from the European Union FEDER funds. AMN is the recipient of a predoctoral contract and NS benefits from a Juan de la Cierva postdoctoral contract, both granted by MINECO, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exopolysaccharide-producing lactic acid bacteria isolated from traditional Algerian dairy products and their application for skim-milk fermentations

  • Bachtarzi, Nadia
  • Kharroub, Karima
  • Ruas-Madiedo, Patricia
Exopolysaccharide (EPS)-producing lactic acid bacteria are used in the dairy industry to obtain products with appropriate sensorial properties. Specific EPS act as stabilizers, thickeners, and/or fat-replacers, and are considered as natural biopolymers. The autochthonous microbiota of foods provides a rich reservoir of biodiversity to find biopolymers for novel applications. In this study, a collection of LAB isolated from homemade Algerian dairy products was screened for a rational selection of EPS-producing strains. Six isolates, identified as Lactobacillus plantarum, presented a stable mucoid/ropy phenotype after several sub-cultivations and they were used to ferment skimmed milk. Those fermented with strains LBIO1 and LBIO28 had higher viscosity, a smooth/creamy texture and presented lower syneresis. The kinetics of growth and EPS-production, followed for 48 h, showed that both strains had similar behaviour, the molar mass (about 2 × 106 Da) and radius of gyration (about 80 nm) of the polymers being also similar. However, LBIO28 was able to increase the apparent viscosity of the fermented milk to a higher extent than LBIO1, which could be related with the earlier accumulation of EPS in the first strain in relation to the gelation point. Thus, these two ropy EPS-producing strains are suitable for different applications in dairy fermentations., This work was financed by the Spanish Ministry of Economy and Competitiveness (MINECO) and FEDER European Union funds through the project AGL2015-64901-R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exopolysaccharides synthesized by Bifidobacterium animalis subsp. lactis interact with TLR4 in intestinal epithelial cells

  • Castro-Bravo, Nuria
  • Margolles Barros, Abelardo
  • Wells, Jerry M.
  • Ruas-Madiedo, Patricia
The toll-like receptors involved in recognition of the exopolysaccharide produced by two isogenic, ropy and non-ropy, Bifidobacterium animalis subsp. lactis strains were investigated. Both strains interact with human embryonic kidney (HEK)-293 cells via TLR2, whereas purified EPSs specifically stimulate TLR4 regardless their molar mass., The MicroHealth group acknowledge the project AGL2015-64901-R (including FEDER European Union funds) from the Ministry of Economy, Industry and Competiveness (MINECO). N. Castro-Bravo thanks her FPI fellowship to the MINECO (BES2013-063984)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The biogenic amines putrescine and cadaverine show in vitro cytotoxicity at concentrations that can be found in foods

  • Río Lagar, Beatriz del
  • Redruello, Begoña
  • Linares, Daniel M.
  • Ladero Losada, Víctor Manuel
  • Ruas-Madiedo, Patricia
  • Fernández García, María
  • Martín, M. Cruz
  • Álvarez González, Miguel Ángel
Putrescine and cadaverine are among the most common biogenic amines (BA) in foods, but it is advisable that their accumulation be avoided. Present knowledge about their toxicity is, however, limited; further research is needed if qualitative and quantitative risk assessments for foods are to be conducted. The present work describes a real-time analysis of the cytotoxicity of putrescine and cadaverine on intestinal cell cultures. Both BA were cytotoxic at concentrations found in BA-rich foods, although the cytotoxicity threshold for cadaverine was twice that of putrescine. Their mode of cytotoxic action was similar, with both BA causing cell necrosis; they did not induce apoptosis. The present results may help in establishing legal limits for both putrescine and cadaverine in food, This work was funded by the Spanish Ministry of Economy and Competitiveness (AGL2016-78708-R and AGL2015-64901-R), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Bifidobacteria potencialmente probiótica como terapia coadyuvante en el tratamiento de la diarrea neonatal producida por Clostridium difficile en lechones

  • Valdés-Varela, Lorena
  • Grzeskowiak, Lukasz
  • Gueimonde Fernández, Miguel
  • Ruas-Madiedo, Patricia
Trabajo presentado en la 12ª Reunión de la Red Española de Bacterias Lácticas (RedBAL): Participación de las bacterias lácticas en la salud humana y en la calidad y seguridad alimentaria, celebrada en Sevilla (España) el 17 y 18 de mayo de 2018, Clostridium difficile es un patógeno causante de desórdenes gastrointestinales en seres humanos y en animales y se han identificado cepas similares en ambos (como los ribotipos 027 y 078), lo cual sugiere una posible transmisión del patógeno entre los animales y el hombre (zoonosis). Durante los últimos 15 años, la epidemiología de C. difficile ha cambiado debido, entre otros factores, a la aparición de cepas ¿hipervirulentas¿, siendo las más representativas algunas de las incluidas en los ribotipos 027 y 078. Estas cepas a menudo se asocian con casos más severos de enfermedad, dificultades en el tratamiento de la patología y mayor porcentaje de mortalidad. El ribotipo 078 se ha descrito como el predominante en cerdos, terneros y en la venta de carne al por menor, lo que nos plantea la posibilidad de que este microorganismo pueda ser transmitido por los alimentos. C. difficile se ha descrito como la mayor causa de enteritis en lechones recién nacidos (de 1-7 días). La tasa de mortalidad asociada a brotes de infección asociada a C. difficile (ICD) es variable, aunque puede llegar hasta el 16%, y en los lechones recuperados se ha descrito un retraso en el crecimiento y un menor peso al destete. El cuadro clínico de ICD es el resultado de los efectos celulares de las exotoxinas (fundamentalmente A y B) y de la respuesta inmunológica del individuo en el intestino grueso. Un enfoque terapéutico interesante para reducir los síntomas asociados a ICD sería el desarrollo de agentes que fueran capaces de reducir la carga y actividad de estas toxinas en el intestino. En nuestro grupo hemos desarrollado un modelo in vitro basado en la monitorización continua del comportamiento de líneas celulares intestinales, a través de medidas de impedancia empleando la tecnología ¿Real Time Cell Analyzer¿ (RTCA), que es eficaz para estudiar la cinética de citotoxicidad de los sobrenadantes procedentes de un cultivo toxigénico de C. difficile1. Estudios previos con este modelo nos permitieron evaluar el potencial probiótico de distintas cepas de bifidobacterias y lactobacilos para contrarrestar el efecto citotóxico de C. difficile LMG21717 sobre la línea intestinal HT29. Bifidobacterium longum IPLA20022 fue la que presentó la mayor capacidad protectora sobre esta línea celular y la más efectiva en reducir los niveles de toxinas en el sobrenadante del clostridio2. Además, esta bifidobacteria fue capaz de reducir la toxicidad de cepas de colección y aislados clínicos (origen humano) con distintos ribotipos de C. difficile sobre HT29. En el presente trabajo hemos analizado la capacidad de esta bifidobacteria para atenuar el efecto citotóxico de una cepa de C. difficile aislada de una diarrea de un lechón (perteneciente al ribotipo 078) sobre líneas celulares intestinales. Los resultados preliminares muestran que el sobrenadante de B. longum IPLA20022 también es eficaz para contrarrestar el efecto citotóxico de la cepa hipervirulenta de C. difficile de origen animal sobre la línea celular HT29., Financiación: Proyecto AGL2015-64901-R (MINECO), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Screening of exopolysaccharide-producing LAB isolated from traditional Algerian dairy products and preliminary characterization of selected strains during skim-milk fermentations

  • Bachtarzi, Nadia
  • Kharroub, Karima
  • Ruas-Madiedo, Patricia
Trabajo presentado en la 12ª Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en Sevilla (España) del 17 al 18 de mayo de 2018, Introduction: Some lactic acid bacteria (LAB) are able to secrete carbohydrate polymers which are known as exopolysaccharides (EPS) which mostly form a protective layer for the producing bacteria. In addition, EPS-producing LAB have a valuable application in dairy industry for the improvement of the viscosity, texture and `mouthfeel¿ of fermented milk products. There is a high consumer demand for smooth and creamy yoghurt-like products, with low fat or sugar content and low levels of additives; therefore, in situ production of EPS during milk fermentation is a cost less, natural and viable alternative. Therefore, the selection of novel strains from natural sources is crucial to find new desired EPS-phenotype for the food industry. Objective: The aim of this work was to selected EPS-producing strains, from a collection of LAB isolates obtained from traditional Algerian products, having technological aptitudes to be used in dairy fermentations. Results: A collection of 584 LAB isolates was screened for the detection of a ¿ropy¿ phenotype either in the colony or in liquid culture. Six EPS-producing strains were selected presenting this stable character after several successive sub-cultivations. They were characterized using a polyphasic approach, including phenotypical characterization and 16S rRNA gene identification, and all of them, which were isolated from different geographical origin, belonged to species Lactobacillus plantarum. The ability of these 6 EPS-producing strains to produce EPS in skim-milk after 24 h of fermentation was checked; the appearance of the fermented milk was evaluated on the basis of the following criteria: syneresis, macrostructure, presence of the ropy character, as well as the strength of the gel. For this preliminary characterization, 3 out of 6 strains (Lbio1, Lbio2, and Lbio28) were giving a viscous appearance, with low syneresis and smooth consistency. The measurement of the apparent viscosity, by means of Posthumus funnel, of skim-milks (separately) fermented with the 3 strains in comparison with a non-ropy strain confirmed the viscosifying capability of the selected strains. Finally, the kinetics of EPS production during skim-milk fermentation was carried out for strains Lbio1 and Lbio28 showing a final yield (after 24 h) of 74 mg/L and 205 mg/L, respectively. Conclusion: from this preliminary characterization of Algerian indigenous LAB, we have selected EPS-producing strains that can be good candidates for the improvement of the physical-chemical properties of fermented milks., This work was funded by project AGL2015-64901-R (MINECO, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Escrutinio de la producción de GABA (ácido gamma-aminobutírico) en miembros del género Bifidobacterium

  • Ruíz García, Lorena
  • Duranti, Sabrina
  • Milani, Christian
  • Lugli, Gabriele Andrea
  • Ventura, Marco
  • Margolles Barros, Abelardo
  • Ruas-Madiedo, Patricia
Trabajo presentado en la 13ª Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en Madrid (España) del 17 al 18 de junio de 2019, El ácido gamma-amino butírico (GABA) es el principal neurotransmisor inhibidor del sistema nervioso central, regula múltiples procesos fisiológicos en el cuerpo humano y su deficiencia se ha relacionado con trastornos de ansiedad y depresión. Además, en los últimos años, la suplementación dietética con GABA se ha asociado con propiedades antihipertensivas, analgésicas y antidepresivas y, por tanto, existe un interés creciente en la identificación de cepas probióticas con capacidad de producción de GABA, que podrían actuar como vectores para el suministro de este neurotransmisor en el intestino humano. Se sabe que algunas bacterias del ácido láctico, incluyendo algunas cepas de lactobacilos y estreptococos, son capaces de producir GABA, aunque esta actividad ha sido poco explorada en miembros del género Bifidobacterium. En este trabajo se estudió la capacidad de producción de GABA entre los miembros del género Bifidobacterium combinando aproximaciones in silico e in vitro. Se llevó a cabo un análisis in silico de los genomas de Bifidobacterium disponibles en la base de datos del NCBI, para determinar la ocurrencia de los genes responsables en la producción de GABA en este grupo. En base a los resultados, se determinó la capacidad de producción de GABA en una colección de 58 cepas de Bifidobacterium, principalmente compuestas por miembros de la especie B. adolescentis. Para ello, las cepas se cultivaron en presencia del precursor de GABA, glutamato monosódico, y las concentraciones de GABA y glutamato monosódico residual se determinaron en sobrenadantes libres de células mediante cromatografía líquida de alto rendimiento. La presencia de los genes gadB y gadC, que codifican una glutamato descarboxilasa y un sistema antiportador glutamato / GABA, respectivamente, en las cepas productoras de GABA se determinó mediante PCR. En el género Bifidobacterium, los genes gadB y gadC se encuentran fundamentalmente en cepas pertenecientes a la especie B. adolescentis. Además, el 25% de las cepas analizadas fueron capaces de transformar más del 90 % del glutamato monosódico proporcionado, a GABA. En conclusión, la producción de GABA es un rasgo relativamente común en B. adolescentis que podrían representar posibles candidatos para la producción de este compuesto bioactivo in vivo en el intestino humano. Agradecimientos / Fuente de financiación: se agradece el excelente trabajo técnico de Diana Luaces e Isabel Cuesta. Este estudio ha sido financiado con el proyecto AGL2015-64901-R, Este estudio ha sido financiado con el proyecto AGL2015-64901-R
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genotypic and Phenotypic characterization of Fecal Staphylococcus epidermidis Isolates Suggests Plasticity to adapt to different human body sites

  • García-Gutiérrez, Enriqueta
  • Walsh, Calum J.
  • Sayavedra, Lizbeth
  • Diaz-Calvo, Teresa
  • Thapa, Dines
  • Ruas-Madiedo, Patricia
  • Mayer, Melinda J.
  • Cotter, Paul D.
  • Narbad, Arjan
Staphylococcus epidermidis is a commensal species that has been increasingly identified as a nosocomial agent. Despite the interest, little is known about the ability of S. epidermidis isolates to adapt to different ecological niches through comparisons at genotype or phenotype levels. One niche where S. epidermidis has been reported is the human gut. Here, we present three S. epidermidis strains isolated from feces and show that they are not phylogenetically distinct from S. epidermidis isolated from other human body sites. Both gut and skin strains harbored multiple genes associated with biofilm formation and showed similar levels of biofilm formation on abiotic surfaces. High-throughput physiological tests using the BIOLOG technology showed no major metabolic differences between isolates from stool, skin, or cheese, while an isolate from bovine mastitis showed more phenotypic variation. Gut and skin isolates showed the ability to metabolize glycine-conjugated bile acids and to grow in the presence of bile, but the gut isolates exhibited faster anaerobic growth compared to isolates of skin origin., The authors are grateful for funding from Walsh Fellowship Project 2015066 (EG-G) and BBSRC Institute Strategic Programme Grant BB/R012490/1, BBS/E/F/000PR10356 (Quadram Institute Biosciences, LS, MM, and AN). Research in the Cotter lab is also supported by SFI; PI award “Obesibiotics” (SFI/11/PI/1137) and centre grant “APC Microbiome Institute” (SFI/12/RC/2273). Research at IPLA CSIC was financed by projects i-link1031 (CSIC) and AGL2015 64901 R (MINECO Spanish Research Plan and FEDER funds)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exopolysaccharide Producing Bifidobacterium animalis subsp. lactis Strains Modify the Intestinal Microbiota and the Plasmatic Cytokine Levels of BALB/c Mice According to the Type of Polymer Synthesized

  • Sabater, Carlos
  • Molinero, Natalia
  • Castro-Bravo, Nuria
  • Diez-Echave, Patricia
  • Hidalgo-García, Laura
  • Delgado, Susana
  • Sánchez García, Borja
  • Gálvez, Julio
  • Margolles Barros, Abelardo
  • Ruas-Madiedo, Patricia
Bacteria-host interactions are mediated by different microbial associated molecular patterns which are most often surface structures such as, among others, exopolysaccharides (EPSs). In this work, the capability of two isogenic EPS-producing Bifidobacterium animalis subsp. lactis strains to modulate the gut microbiota of healthy mice, was assessed. Each strain produces a different type of polymer; the ropy strain S89L synthesized a rhamnose-rich, high-molecular weight EPS in highest abundance than the non-ropy DMS10140 one. BALB/c mice were orally fed for 10 days with milk-bifidobacterial suspensions and followed afterward for 7 post-intervention days (wash-out period). The colonic content of mice was collected in several sampling points to perform a metataxonomic analysis. In addition, the influence of specific microbial clades, apparently stimulated by the ropy and non-ropy strains, on mouse plasmatic cytokine levels was investigated through hierarchical association testing. Analysis of 16S rRNA gene sequences showed that the abundance of Firmicutes phylum significantly increased 7 days after cessing the treatment with both strains. The relative abundance of Alloprevotella genus also rose, but after shorter post-treatment times (3 days for both DMS10140 and S89L strains). Some bacterial clades were specifically modulated by one or another strain. As such, the non-ropy DMS10140 strain exerted a significant influence on Intestinomonas genus, which increased after 4 post-administration days. On the other hand, feeding with the ropy strain S89L led to an increase in sequences of Faecalibaculum genus at 4 post-treatment days, while the abundance of Erysipelotrichaceae and Lactobacillaceae families increased for prolonged times. Association testing revealed that several lactobacilli and bifidobacterial significantly stimulated by ropy S89L strain were positively associated with the levels of certain cytokines, including IL-5 and IL-27. These results highlight relevant changes in mice gut microbiota produced after administration of the ropy S89L strain that were associated to a potential immune modulation effect., The MicroHealth group acknowledge the projects AGL2015- 64901-R (AEI/FEDER, UE) and RTI2018-096339-B-I00 (MCIU/AEI/FEDER, UE), as well as the grant IDI/2018/000236 from the “Plan for Research, Development and Innovation of the Principado de Asturias 2018–2020” co-financed by the European Regional Development Funds (FEDER). NC-B thanks her FPI fellowship to the MINECO (BES2013-063984). CS acknowledges his Postdoctoral research contract funded by the “Instituto de Investigación Sanitaria del Principado de Asturias” (ISPA). The CIBER-EHD was funded by the Instituto de Salud Carlos III. PDE and LH-G are predoctoral fellows from University of Granada of “Programa de Doctorado: Medicina Clínica y Salud Pública.” We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Estreptococos en muestras de aspirado duodenal en casos de dispepsia funcional

  • Molinero, Natalia
  • Tojo, Rafael
  • Corell, Paula
  • Mira, Alex
  • Margolles Barros, Abelardo
  • Ruas-Madiedo, Patricia
  • Delgado, Susana
Trabajo presentado a la 13ª Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en el Centro de Investigaciones Biológicas (CIB-CSIC) en Madrid del 17 al 18 de junio de 2019., Introducción: La dispepsia funcional es una entidad clínica en la que no se encuentra una causa orgánica para los síntomas de molestias en la parte superior del tracto gastrointestinal (TGI). Su determinación se produce por exclusión de otras patologías, por lo que estos sujetos se someten normalmente a una endoscopia para tomar muestras del TGI superior, llegando hasta la primera porción del intestino delgado o duodeno. Aquí, las comunidades microbianas han sido muy poco estudiadas en comparación con las que habitan posiciones más distales en el intestino grueso. Sin embargo, es en el duodeno donde tiene lugar la secreción biliar y pancreática, y la digestión de las grasas. Una de las poblaciones más representativas en este nicho parece ser la de estreptococos, pero se han realizado muy pocos trabajos en sujetos sanos por la dificultad de acceso a las muestras. Objetivos: Llevar a cabo un estudio microbiológico mediantes diversas técnicas moleculares y de cultivo de muestras de aspirados duodenales en sujetos, aparentemente sanos, con el fin de identificar si los estreptococos son dominantes en este ecosistema, y asilar cepas comensales de este género de interés. Materiales y Métodos: Aspirados duodenales de sujetos con dispepsia se cultivaron en medio BHI incubándose a 37°C en condiciones de aerobiosis y microaerofilia. Además de los recuentos en placa y aislamiento de colonias para su posterior identificación (mediante secuenciación del gen SOD), se determinó la carga microbiana total mediante qPCR usando cebadores conservados para el ADNr 16S. Por otro lado, se determinaron las comunidades microbianas presentes mediante metagenómica filogenética. Resultados: En las muestras se obtuvieron recuentos en cultivo en torno a 104 ufc/ml, mientras que por qPCR los niveles fueron del orden de una unidad logarítmica superior (4,5x105). La asignación taxonómica de las secuencias obtenidas mediante tecnología Illumina reveló que las mayores abundancias relativas se correspondían con secuencias del género Streptococcus (~42%). Se obtuvieron un total de 61 aislados correspondientes con estreptococos del grupo salivarius (30): 18 Streptococcus salivarius y 12 S. vestibularis, grupo mitis (21): 8 S. parasanguinis, 6 S. oralis, 5 S. mitis, 1 S. infantis y 1 S. peroris y grupo anginosus (8): 6 S. anginosus y 2 S. constellatus. Se aislaron también un par de cepas con una identidad menor del 96% con otras especies de estreptococos y hemos procedido a la secuenciación de sus genomas. Conclusiones: Los resultados microbiológicos del ambiente duodenal muestran una dominancia de estreptococos del grupo salivarius, tal y como estaba reportado, pero también la presencia de otras especies distintas del grupo viridans, en concreto del grupo anginosus, cuyas secuencias fueron también encontradas mediante metagenómica filogenética, y de las cuales se sabe muy poco de su incidencia y significado clínico. El estudio de estos aislados posibilitará una mejor caracterización del ecosistema microbiano del TGI superior., A Chotika Mahatkomol y Atima Wongwan del programa internacional IFMSA / Ayuda ID//2018/00236 y proyecto AGL2015-64901-R.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Probiotics for the prevention and treatment of Clostridium difficile infection

  • Valdés-Varela, Lorena
  • Gueimonde Fernández, Miguel
  • Ruas-Madiedo, Patricia
Probiotics have been claimed as a valuable tool to restore the balance in the intestinal microbiota following a dysbiosis caused by, among other factors, antibiotic therapy. This perturbed environment could favor the overgrowth of Clostridium difficile, and in fact, the occurrence of C. difficile-associated infections (CDI) is increasing in recent years. In spite of the high number of probiotics able to in vitro inhibit the growth and/or toxicity of this pathogen, its application for treatment or prevention of CDI is still scarce since there are not enough well-defined clinical studies supporting efficacy. Only a few strains, such as Lactobacillus rhamnosus GG and Saccharomyces boulardii, have been studied in more extent. The increasing knowledge about the probiotic mechanisms of action against C. difficile, some of them reviewed here, makes promising the application of these live biotherapeutic agents against CDI. Nevertheless, more effort must be paid to standardize the clinical studies conducted to evaluate probiotic products, in combination with antibiotics, in order to select the best candidate for C. difficile infections., The funds supporting this research topic in our group are given by the Spanish Ministry of Economy and Competitiveness (current project AGL2015-64901-R) partially co-funded by FEDER (European Union) grants., Peer reviewed